Evidence map›Paper›PMID 22562284›Full record

GuidelineJournal of assisted reproduction and genetics2012

Recommendations for fertility preservation in patients with lymphomas.

Kirsten Tryde Schmidt, Claus Yding Andersen, ISFP Practice Committee

Erratum issuedOpen access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Journal of assisted reproduction and genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2013
    Guideline
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Fertility preservation in men with cancer.Reproductive medicine and biology · 2014
    Review
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kirsten Tryde SchmidtThe Fertility Clinic, Rigshospitalet - University Hospital of Copenhagen, Copenhagen, Denmark, kirsten.tryde.schmidt@rh.regionh.dk.
Claus Yding Andersen
ISFP Practice Committee
Rigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis guideline aims to serve as a reference for fertility specialists and other specialists working with young patients at risk of premature ovarian insufficiency (POI) or testicular dysfunction (TD) due to treatment of Hodgkin or Non-Hodgkin lymphoma.

methodsPubMed search of articles addressing risk of POI and TD according to different treatment protocols used in lymphoma patients. PubMed search of articles presenting different options for fertility treatment in cancer patients.

resultsThe risk of POI/TD depends on the protocol used with the highest risk in patients treated with haematopoietic stem cell transplantation/bone marrow transplantation (HSCT/BMT) and the lowest risk in patients treated with ABVD (Adriamycin, Bleomycin, Vincristine and Decarbazine). The different options of fertility preservation are discussed and their relevance according to treatment protocol, age of the patient and urgency to start treatment.

conclusionFertility issues should be discussed with all women of fertile age. Fertility preservation should be offered to young women when relevant. Children should be informed together with their parents. All men should be offered semen cryopreservation regardless of protocol used. At present, there are no established methods of fertility preservation in pre-pubertal boys. This guideline offers suggestions to the most preferred methods of fertility preservation according to treatment protocol, age of the patient, and urgency to start treatment.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBleomycinCryopreservationDacarbazineDoxorubicinFemaleFertility PreservationGonadotropin-Releasing HormoneHodgkin DiseaseHumansLymphoma, Non-HodgkinMaleOocytesOvaryPrimary Ovarian InsufficiencySemen PreservationBleomycinDacarbazineDoxorubicinGonadotropin-Releasing HormoneVinblastine

Identifiers

PMID22562284
PMCPMC3370035
OpenAlexW2040834678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.